Patent · US Active

KRAS mutant protein inhibitors

US11161847B2 · kind B2 · utility

1Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2021
Grant dateNov 2, 2021
Priority date
Expiry dateMar 31, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to a KRAS mutant protein inhibitors of formula (I), a composition containing the inhibitors and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.